- Home
- IRON vs DMLP Comparison
IRON vs DMLP Comparison
Compare IRON & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- DMLP
- Stock Information
- Founded
- IRON 2017
- DMLP 2003
- Country
- IRON United States
- DMLP United States
- Employees
- IRON N/A
- DMLP N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- DMLP Oil & Gas Production
- Sector
- IRON Health Care
- DMLP Energy
- Exchange
- IRON Nasdaq
- DMLP Nasdaq
- Market Cap
- IRON 1.4B
- DMLP 1.3B
- IPO Year
- IRON N/A
- DMLP N/A
- Fundamental
- Price
- IRON $59.46
- DMLP $33.09
- Analyst Decision
- IRON Strong Buy
- DMLP
- Analyst Count
- IRON 10
- DMLP 0
- Target Price
- IRON $72.00
- DMLP N/A
- AVG Volume (30 Days)
- IRON 431.6K
- DMLP 87.7K
- Earning Date
- IRON 11-12-2024
- DMLP 10-31-2024
- Dividend Yield
- IRON N/A
- DMLP 12.04%
- EPS Growth
- IRON N/A
- DMLP 4.55
- EPS
- IRON N/A
- DMLP 2.78
- Revenue
- IRON N/A
- DMLP $166,454,000.00
- Revenue This Year
- IRON N/A
- DMLP N/A
- Revenue Next Year
- IRON N/A
- DMLP N/A
- P/E Ratio
- IRON N/A
- DMLP $11.88
- Revenue Growth
- IRON N/A
- DMLP 14.26
- 52 Week Low
- IRON $25.60
- DMLP $27.90
- 52 Week High
- IRON $77.60
- DMLP $35.74
- Technical
- Relative Strength Index (RSI)
- IRON 58.39
- DMLP 58.02
- Support Level
- IRON $63.21
- DMLP $32.25
- Resistance Level
- IRON $68.73
- DMLP $33.72
- Average True Range (ATR)
- IRON 3.49
- DMLP 0.90
- MACD
- IRON 0.52
- DMLP 0.01
- Stochastic Oscillator
- IRON 61.25
- DMLP 70.85
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.